Autophagy functions as a nutrient‑rationing system that decides which intracellular components are expendable during prolonged resource scarcity, not as a constitutive cleanup crew. We hypothesize that the decision to allocate autophagic activity toward survival versus self‑destruction is governed by a circadian‑driven AMP‑activated protein kinase (AMPK) pulse that sets a triage threshold. When the AMPK pulse aligns with the cell’s intrinsic circadian peak, autophagy selectively recycles bulk cytosol and non‑essential organelles, generating ATP and amino acids that sustain homeostasis without compromising essential proteins. Conversely, when autophagy is induced outside this window—by pharmacological agents or nutrient perturbations that do not respect the circadian AMPK rhythm—the same autophagic flux degrades short‑lived anti‑apoptotic regulators (e.g., Mcl‑1, Bcl‑xl) and disrupts intracellular transport logistics, converting a protective response into a catabolic death signal.

This mechanistic extension builds on several observations: (1) autophagy primarily recycles nutrients during starvation, producing metabolic substrates rather than removing damaged material [1]; (2) selective degradation follows nutrient content, not damage status, indicating a rationing logic [2]; (3) plant autophagy mutants fail to remobilize nitrogen‑rich compounds during senescence, showing impaired nutrient redistribution [3]; (4) sustained AMPK hyper‑activation drives synaptic loss and neuronal dysfunction through excessive autophagy [4]; (5) senescent cells maintain high basal autophagy that paradoxically fuels mTORC1 signaling, illustrating how dysregulated autophagy can sustain maladaptive metabolism [5]; (6) autophagy modulates intracellular transport speed and cellular logistics, linking degradation dynamics to neuronal homeostasis [6]; (7) mTOR inhibition extends lifespan by improving metabolic efficiency and nutrient redistribution, not just by clearing waste [7]; and (8) aged astrocytes lose circadian control of endocytosis‑related genes, suggesting a link between circadian timing and autophagic capacity [8].

We propose that the circadian AMPK pulse acts as a metabolic gatekeeper: its amplitude and timing determine whether autophagosomes preferentially engulf lipid droplets, glycogen stores, or ribosomes (survival mode) versus targeting BH3‑only proteins and vesicular trafficking components (death mode). The gatekeeper function explains why simply boosting autophagy—e.g., with constant rapamycin treatment—does not uniformly improve healthspan and why timing interventions to circadian peaks may be critical.

Testable predictions arise directly from this model. In cultured hippocampal neurons, we will measure autophagic flux (LC3‑II turnover with bafilomycin A1), AMPK phosphorylation (p‑AMPK Thr172), and cell viability under four conditions: (1) vehicle control; (2) rapamycin administered at the circadian peak of AMPK activity (determined by real‑time luciferase reporters); (3) rapamycin administered at the AMPK trough; (4) genetic disruption of circadian AMPK oscillation (Bmal1 knockout) with constant rapamycin. We predict that condition 2 will show increased survival despite comparable LC3‑II levels to condition 3, whereas condition 3 will exhibit elevated caspase‑3 activation and reduced neurite length. Disrupting the circadian AMPK rhythm (condition 4) should abolish the timing effect, rendering rapamycin toxic regardless of administration time.

Falsifiability is straightforward: if autophagic flux induced at the AMPK trough does not reduce survival or increase apoptotic markers relative to peak‑timed induction, or if Bmal1 loss does not eliminate the timing‑dependent difference, the hypothesis would be refuted. Conversely, confirmation would support the view that autophagy’s role as a siege rationing system is dynamically gated by circadian energy signaling, shifting the focus from maximal autophagy induction to precisely timed metabolic triage.